NCT06454500

Brief Summary

The goal of this randomized controlled trial is to compare the effects of a clinical decision support tool consisting of a 48-hour stop order for indwelling urinary catheters versus no clinical decision support in hospitalized patients with indwelling urinary catheters. The main questions it aims to answer are: \- Does the presence of an automated stop order integrated as part of a clinical decision support tool reduce dwell time of urinary catheters and the rate of catheter associated urinary tract infections? Participants who have indwelling urinary catheters ordered will be randomized to either have these orders automatically expire after 48 hours unless an action is taken or have orders without expiration. Researchers will compare the urinary catheter dwell time and the rate of catheter associated urinary tract infections between the two groups.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
79,369

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Aug 2021

Geographic Reach
1 country

8 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 17, 2021

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 4, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 4, 2023

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

June 6, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 12, 2024

Completed
Last Updated

June 20, 2024

Status Verified

June 1, 2024

Enrollment Period

1.6 years

First QC Date

June 6, 2024

Last Update Submit

June 17, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Urinary catheter dwell time

    The time between urinary catheter insertion and removal

    Measured from time of catheter insertion until catheter removal or hospital discharge if the catheter was not removed, up to 250 days.

Secondary Outcomes (3)

  • Catheter Associate Urinary Tract Infection (CAUTI) rate

    The development of a CAUTI was assessed from time of catheter insertion until either catheter removal or hospital discharge if the catheter was not removed, up to 250 days.

  • CAUTI population rate

    The development of a CAUTI was assessed from time of catheter insertion until either catheter removal or hospital discharge if the catheter was not removed, up to 250 days.

  • CAUTI Free survival

    The development of a CAUTI was assessed from time of catheter insertion until either catheter removal or hospital discharge if the catheter was not removed, up to 250 days.

Study Arms (2)

Stop Orders

EXPERIMENTAL

For participants in this arm, a clinical decision support tool consisting of stop orders and an expiring alert that was displayed to care team clinicians.

Other: Clinical decision support

Continuous Orders

NO INTERVENTION

For participants in this arm, no clinical decision support or alerts were displayed to care team clinicians and the urinary catheter order was continuous.

Interventions

A 48 hour expiration on orders placed for indwelling urinary catheters.

Stop Orders

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Admitted to hospital
  • At least 18 years old
  • Has order placed for indwelling urinary catheter

You may not qualify if:

  • Indication for urinary catheter labeled as either "Chronic" or "Placed by urology"

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (8)

NewYork-Presbyterian Westchester

Bronxville, New York, 10708, United States

Location

NewYork-Presbyterian Brooklyn Methodist Hospital

Brooklyn, New York, 11215, United States

Location

NewYork-Presbyterian Hudson Valley Hospital

Cortlandt Manor, New York, 10567, United States

Location

NewYork-Presbyterian Queens

Flushing, New York, 11355, United States

Location

NewYork-Presbyterian Columbia University Irving Medical Center

New York, New York, 10032, United States

Location

NewYork-Presbyterian Allen Hospital

New York, New York, 10034, United States

Location

NewYork-Presbyterian Lower Manhattan Hospital

New York, New York, 10038, United States

Location

NewYork-Presbyterian Weill Cornell Medical Center

New York, New York, 10065, United States

Location

MeSH Terms

Conditions

Cross Infection

Condition Hierarchy (Ancestors)

InfectionsIatrogenic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Jason Adelman, MD, MS

    Columbia University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 6, 2024

First Posted

June 12, 2024

Study Start

August 17, 2021

Primary Completion

April 4, 2023

Study Completion

April 4, 2023

Last Updated

June 20, 2024

Record last verified: 2024-06

Data Sharing

IPD Sharing
Will not share

Locations